Differentiating multiple sclerosis (MS) from other relapsing inflammatory autoimmune
diseases of the central nervous system such as neuromyelitis optica spectrum disorder …

OBJECTIVE This article reviews the clinical features, MRI characteristics, diagnosis, and
treatment of aquaporin-4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 …

MRI and clinical features of myelin oligodendrocyte glycoprotein (MOG)-antibody disease
may overlap with those of other inflammatory demyelinating conditions posing diagnostic …

Background: We aimed to assess the frequency of new asymptomatic lesions on brain and
spinal imaging (magnetic resonance imaging (MRI)) and their association with subsequent …

Background and Objectives Knowledge of the evolution of CNS demyelinating lesions within
attacks could assist diagnosis. We evaluated intra-attack lesion dynamics in patients with …

Background: Magnetic resonance imaging (MRI) T2-lesions resolve more often in myelin
oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) than aquaporin …

BACKGROUND—Myelin oligodendrocyte glycoprotein (MOG), a protein on the surface of
oligodendrocytes, was once considered as a potential antibody target in multiple sclerosis …

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an
immune-mediated demyelinating disease that is challenging to differentiate from multiple …

Objectives To determine whether progression independent of relapse activity (PIRA) is
present in Aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder (AQP4+ …

Transverse myelitis (TM) is the second most common presentation of myelin
oligodendrocyte antibody-associated disease (MOGAD), occurring in approximately 26% of …